Professor of Medicine, University Tex San Antonio
Oncology
Dr. Athanassios Argiris, MD
|
|
Give Review
Athanassios Argiris, MD works in the field of Oncology. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACP)". Doctor Athanassios Argiris, MD has written publications. He has 14 publications published with PubMed. The lastest paper is: 'Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.'
Publications
- Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary Tumors.
- Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative On...
- A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
- Prognostic significance of human papillomavirus in recurrent or metastatic head and neck Cancer: an analysis of Eastern Cooperative Oncology Group trials.
- Posttraumatic stress disorder (PTSD) symptoms in newly diagnosed head and neck Cancer patients and their partners.
- Erlotinib, erlotinib-sulindac vs. placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck Cancer.
- Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung Cancer.
- Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of ...
- Current status and future directions in induction chemotherapy for head and neck Cancer.
- Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology ...
- Pemetrexed in head and neck Cancer: A systematic review.
- Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.
- Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck Cancer: first human application and potential antitumor mechanisms.
Schools
University Of Athens School Of Health Sciences
Beth Israel Med Center
Yale University School Of Med
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
Education
-
Mount Sinai Beth Israel -
University of Athens
Hospital
-
South Texas Veterans Health Care System
Helpful Reviews
Similar Doctors
|
|
Dr. Jane M. Raymond, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antonios Christou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Friedland, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nancy E. Davidson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ajlan Atasoy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Kirkwood, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Dulabh K. Monga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan Bahary, MD
This Doctor is OpenDoctor Recommended.
|